Developing an inhaled drug product

Inhaled drug development

Quotient has a 30 year track record in the development and manufacturing of inhaled drug products. We have experience across a range of drug delivery platforms including dry powder inhalers (DPIs) and solutions/suspensions for inhalation.  With integrated capabilities and vast knowledge of nasal and pulmonary delivery, we help our clients accelerate their molecules from first-in-human, through to proof-of-concept and into full development.
A scientist working the Modu-C capsule filling machine

Integrated capabilities and expertise for nasal and pulmonary delivery

Our extensive expertise and capabilities for nasal and pulmonary delivery include:

  • Pre-formulation and API characterization
  • Formulation and process development
  • Inhaled device evaluation and selection
  • Clinical manufacturing and supply (Phase I-III)
  • Clinical pharmacology assessments

We have a wide range of processing and analytical equipment to support the development and manufacture of inhaled drug products:

  • Spray drying
  • Micronization
  • Blending and encapsulation
  • Aerosol characterization
Ready to get started?
Share your project needs with us.